Cipla Limited (LUX:CIPLA)
Luxembourg
· Delayed Price · Currency is EUR · Price in USD | Market Cap | 10.13B |
| Revenue (ttm) | 2.65B |
| Net Income (ttm) | 430.93M |
| Shares Out | n/a |
| EPS (ttm) | 0.53 |
| PE Ratio | 23.50 |
| Forward PE | 24.36 |
| Dividend | 0.12 (0.83%) |
| Ex-Dividend Date | Jun 26, 2025 |
| Volume | n/a |
| Average Volume | n/a |
| Open | n/a |
| Previous Close | 14.90 |
| Day's Range | n/a |
| 52-Week Range | 14.30 - 18.90 |
| Beta | n/a |
| RSI | 45.92 |
| Earnings Date | May 11, 2026 |
About Cipla
Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer’s disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obe... [Read more]
Financial Performance
In fiscal year 2025, Cipla's revenue was 272.67 billion, an increase of 6.78% compared to the previous year's 255.37 billion. Earnings were 52.73 billion, an increase of 27.93%.
Financial numbers in INR Financial StatementsNews
Pharma sector stocks today, Feb 27: Dr. Reddys Lab down 1.14%, Cipla falls 1.04%, Natco Pharma up 1.09%
The Indian pharmaceutical sector showed mixed performance on February 27, 2026, during early morning trading hours. Data from around 9:24...
Cipla shares fall over 2% after USFDA classifies Greece facility inspection as OAI
Shares of Cipla declined more than 2% in early trade after the company disclosed that the United States Food and...
Top stocks to watch today – February 23: Axis Bank, UPL, Vedanta, Adani Ports, SBI Life, NHPC, IDFC First, Cipla and more
Indian markets are expected to react to a mix of corporate developments, regulatory actions, fund-raising plans, order wins and policy...
Nifty 50 top losers today, Feb 12: Cipla, Adani Enterprises, Maruti Suzuki India, INDIGO, Adani Ports and more
Indian equity indices ended lower on February 12, with the Nifty closing below the 25,850 mark amid broad-based selling pressure....
Cipla Launches Win Over Weight Campaign, Igniting a National Conversation on Obesity Care in India
Business Wire India Cipla Limited (BSE: 500087; NSE: CIPLA; and hereafter referred to as "Cipla") today announced the launch of...
Nifty 50 top losers today, Feb 2: Shriram Finance, Axis Bank, Max Healthcare, Infosys, Cipla and more
Indian equity benchmarks ended the February 2 session on a strong note despite volatility, with the Nifty 50 closing above...
Top losers among Nifty 50 stocks in midday trade today, Feb 2: Shriram Finance, Cipla, Trent, Infosys, Axis Bank and more
Indian equity benchmarks were trading in positive territory during midday trade on February 2, even as several frontline stocks witnessed...
Pharma sector stocks today, Feb 2: Cipla down 2%, Lupin falls 1.72%, Torrent Pharma drops 1.92%
The Indian pharma sector showed mixed performance on February 2, 2026, as of around 10:30 AM IST, based on the...
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Dru...
Cipla Ltd (BOM:500087) Q3 2026 Earnings Call Highlights: Strategic Growth Amidst Margin Challenges
Cipla Ltd (BOM:500087) Q3 2026 Earnings Call Highlights: Strategic Growth Amidst Margin Challenges
Q3 2026 Cipla Ltd Earnings Call Transcript
Q3 2026 Cipla Ltd Earnings Call Transcript
Cipla shares fall sharply over 3% as Q3 Net profit drops 57.4% YoY to Rs 674.56 crore, EBITDA down 36.7%
Shares of Cipla fell sharply in Friday’s trade after the company reported weak Q3 results, with pressure coming from a...
Cipla Q3 Results: Net profit falls 57.4% YoY to Rs 674.56 crore, revenue flat at Rs 7,074.48 crore
Cipla reported a mixed performance for the quarter ended 31 December 2025 (Q3 FY26), with revenue remaining largely flat on...
Top Q3 results today, January 23: Adani Green, IndusInd Bank, Cipla, Godrej Consumer Products, JSW Steel and more to announce earnings
More than 50 listed companies are scheduled to declare their Q3FY26 financial results today, January 23, making it an active...
Pharma sector stocks fall today: Cipla drops 1.52%, Divi’s Laboratories falls 0.78%, Alembic Pharma down 0.52%
The Indian pharmaceutical sector experienced a downturn on January 19, 2026, with many listed pharma stocks trading lower in early...
Nifty 50 top losers today, January 16: Eternal, Jio Financial Services, Cipla, Hindalco, Asian Paints and more
The Indian equity benchmarks ended the session slightly higher, with the Nifty 50 closing at 25,694.35, up 0.11%, while the...
Why are Cipla shares down nearly 4% today? Explained
Shares of Cipla fell nearly 4% on Friday, January 16, after the company informed exchanges that it is temporarily pausing...
Top stocks to watch today, January 8: Infosys, Tata Steel, HUDCO, Gland Pharma, Angel One, Cipla and more
Indian equity markets are likely to begin Thursday’s session on a cautious note. Trends from global indices and GIFT Nifty...
Why are Cipla shares down over 3% in trade today? Details
Shares of Cipla declined over 3% in trade today after reports flagged a potential regulatory and earnings risk linked to...
Nifty 50 top losers today, January 1: ITC, Dr. Reddy’s, Bajaj Finance, Tata Consumer Products, ONGC, Cipla and more
Indian equity benchmarks ended the first trading session of 2026 on a mixed note as markets witnessed intraday volatility. The...
Dr Reddy, Cipla, Sun Pharma and other stocks in focus today as Govt bans high-dose Nimesulide formulations
Shares of several pharmaceutical companies are likely to remain in focus after the Ministry of Health and Family Welfare (MoHFW)...
Breaking Barriers in Diabetes Care: Cipla Launches #InhaleTheChange Campaign
Business Wire India Cipla Ltd. today launched its nationwide awareness initiative, #InhaleTheChange, aimed at encouraging better insulin adherence through empowerment,...
Nifty 50 top gainers today, December 26: Titan Company, Nestle India, Hindalco Industries, Cipla and more
Indian equity benchmarks closed lower on December 26, with selling pressure seen across sectors. The BSE Sensex declined 367.25 points,...
Pfizer signs exclusive 5-year supply and marketing pact with Cipla for four key brands
Pfizer Limited on Thursday announced that it has entered into an exclusive supply and marketing agreement with Cipla for four...
Cipla launches Yurpeak, a weekly injection for obesity and type 2 diabetes
Cipla has announced the launch of Yurpeak® (tirzepatide), a once-a-week injectable treatment designed to help manage both obesity and type...